DK0441605T3 - Thiazolidin-derivater med anti-diabetisk virkning samt deres fremstilling og anvendelse - Google Patents
Thiazolidin-derivater med anti-diabetisk virkning samt deres fremstilling og anvendelseInfo
- Publication number
- DK0441605T3 DK0441605T3 DK91300959.3T DK91300959T DK0441605T3 DK 0441605 T3 DK0441605 T3 DK 0441605T3 DK 91300959 T DK91300959 T DK 91300959T DK 0441605 T3 DK0441605 T3 DK 0441605T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- well
- thiazolidine derivatives
- hydrogen
- diabetic action
- Prior art date
Links
- 230000003178 anti-diabetic effect Effects 0.000 title abstract 2
- 150000003548 thiazolidines Chemical class 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- -1 methylene, carbonyl Chemical group 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2802390 | 1990-02-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0441605T3 true DK0441605T3 (da) | 1996-07-29 |
Family
ID=12237153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91300959.3T DK0441605T3 (da) | 1990-02-07 | 1991-02-06 | Thiazolidin-derivater med anti-diabetisk virkning samt deres fremstilling og anvendelse |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5143930A (da) |
| EP (1) | EP0441605B1 (da) |
| KR (1) | KR0184601B1 (da) |
| AT (1) | ATE136544T1 (da) |
| AU (1) | AU637456B2 (da) |
| CA (1) | CA2035832C (da) |
| DE (1) | DE69118565T2 (da) |
| DK (1) | DK0441605T3 (da) |
| ES (1) | ES2088459T3 (da) |
| FI (1) | FI910583A7 (da) |
| GR (1) | GR3020196T3 (da) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991012003A1 (en) * | 1990-02-09 | 1991-08-22 | The Upjohn Company | Use of insulin sensitizing agents to treat hypertension |
| GB9124513D0 (en) * | 1991-11-19 | 1992-01-08 | Smithkline Beecham Plc | Novel process |
| NO302519B1 (no) * | 1991-12-26 | 1998-03-16 | Sankyo Co | Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat |
| NO302471B1 (no) * | 1991-12-26 | 1998-03-09 | Sankyo Co | Tiazolidinforbindelser og farmasöytisk preparat |
| ES2139633T3 (es) * | 1992-08-31 | 2000-02-16 | Sankyo Co | Derivados de oxazolidina con propiedades anti-diabetica y anti-obesidad, su preparacion y su utilizacion terapeutica. |
| FR2696743B1 (fr) * | 1992-10-12 | 1994-12-23 | Adir | Nouveaux composés de thiazolidine dione, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
| TW245716B (da) * | 1992-12-28 | 1995-04-21 | Takeda Pharm Industry Co | |
| JP3195455B2 (ja) * | 1993-01-06 | 2001-08-06 | ウェルファイド株式会社 | キノリン−３−酢酸誘導体、その製造法と用途 |
| TW268952B (da) * | 1993-02-26 | 1996-01-21 | Takeda Pharm Industry Co Ltd | |
| CZ289317B6 (cs) * | 1994-04-11 | 2002-01-16 | Sankyo Company Limited | Heterocyklická sloučenina, farmaceutický prostředek ji obsahující a její pouľití |
| CZ261095A3 (en) * | 1994-10-07 | 1996-04-17 | Sankyo Co | Oxime derivatives, process of their preparation, pharmaceutical composition containing thereof and their use |
| IL118474A (en) * | 1995-06-01 | 2001-08-08 | Sankyo Co | Benzimideol derivatives and pharmaceutical preparations containing them |
| US5919782A (en) * | 1996-05-06 | 1999-07-06 | Dr. Reddy's Research Foundation | Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| US5889025A (en) * | 1996-05-06 | 1999-03-30 | Reddy's Research Foundation | Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| US5801173A (en) * | 1996-05-06 | 1998-09-01 | Dr. Reddy's Research Foundation | Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| ZA973848B (en) * | 1996-05-06 | 1997-12-02 | Reddy Research Foundation | Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them. |
| USRE39266E1 (en) * | 1996-07-01 | 2006-09-05 | Dr. Reddy's Laboratories, Limited | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| US6372750B2 (en) | 1996-07-01 | 2002-04-16 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases |
| US6114526A (en) * | 1996-07-01 | 2000-09-05 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| CA2258949C (en) | 1996-07-01 | 2008-05-06 | Reddy-Cheminor, Inc. | Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| US5885997A (en) * | 1996-07-01 | 1999-03-23 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| TW475931B (en) | 1997-10-08 | 2002-02-11 | Sankyo Co | A substituted condensed heterocyclic compound |
| US6946295B2 (en) * | 1998-06-12 | 2005-09-20 | Cellfor, Inc. | Process for ex vitro sowing and germination of plant somatic embryos |
| US6028088A (en) * | 1998-10-30 | 2000-02-22 | The University Of Mississippi | Flavonoid derivatives |
| TWI284533B (en) * | 1999-05-24 | 2007-08-01 | Sankyo Co | Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant |
| WO2002050024A2 (en) * | 2000-12-18 | 2002-06-27 | Smithkline Beecham Corporation | Thiazolidinediones |
| KR20120107493A (ko) | 2009-12-15 | 2012-10-02 | 메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 | 대사성 질환의 치료를 위한 ｐｐａｒ 절약형 티아졸리딘디온염 |
| MX2012012092A (es) | 2010-04-19 | 2012-12-17 | Metabolic Solutions Dev Co Llc | Sintesis novedosa para compuestos de tiazolidinadiona. |
| PL2603498T3 (pl) | 2010-08-10 | 2017-06-30 | Octeta Therapeutics, Llc | Nowa synteza związków tiazolidynodionu |
| US8895748B2 (en) | 2010-08-10 | 2014-11-25 | Metabolic Solutions Development Company, Llc | Synthesis for thiazolidinedione compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
| JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
| US4873255A (en) * | 1987-02-04 | 1989-10-10 | Sankyo Company Limited | Thiazolidinone derivatives, their preparation and their use |
| WO1989008650A1 (en) * | 1988-03-08 | 1989-09-21 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
| US4933355A (en) * | 1988-04-14 | 1990-06-12 | Sankyo Company Limited | Thiazole derivatives, their preparation and their use in the treatment of diabetes complications |
| GB8919434D0 (en) * | 1989-08-25 | 1989-10-11 | Beecham Group Plc | Novel compounds |
-
1991
- 1991-01-24 US US07/645,108 patent/US5143930A/en not_active Expired - Fee Related
- 1991-02-06 DE DE69118565T patent/DE69118565T2/de not_active Expired - Fee Related
- 1991-02-06 DK DK91300959.3T patent/DK0441605T3/da active
- 1991-02-06 AT AT91300959T patent/ATE136544T1/de not_active IP Right Cessation
- 1991-02-06 EP EP91300959A patent/EP0441605B1/en not_active Expired - Lifetime
- 1991-02-06 CA CA002035832A patent/CA2035832C/en not_active Expired - Fee Related
- 1991-02-06 ES ES91300959T patent/ES2088459T3/es not_active Expired - Lifetime
- 1991-02-07 AU AU70906/91A patent/AU637456B2/en not_active Ceased
- 1991-02-07 FI FI910583A patent/FI910583A7/fi unknown
- 1991-02-07 KR KR1019910002101A patent/KR0184601B1/ko not_active Expired - Fee Related
-
1996
- 1996-06-12 GR GR960401562T patent/GR3020196T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2035832A1 (en) | 1991-08-08 |
| DE69118565D1 (de) | 1996-05-15 |
| DE69118565T2 (de) | 1997-01-09 |
| EP0441605A2 (en) | 1991-08-14 |
| ATE136544T1 (de) | 1996-04-15 |
| CA2035832C (en) | 2000-08-29 |
| AU637456B2 (en) | 1993-05-27 |
| EP0441605A3 (en) | 1992-01-22 |
| ES2088459T3 (es) | 1996-08-16 |
| AU7090691A (en) | 1991-08-08 |
| GR3020196T3 (en) | 1996-09-30 |
| US5143930A (en) | 1992-09-01 |
| FI910583A7 (fi) | 1991-08-08 |
| HK1005451A1 (en) | 1999-01-08 |
| KR910015552A (ko) | 1991-09-30 |
| EP0441605B1 (en) | 1996-04-10 |
| KR0184601B1 (ko) | 1999-05-01 |
| FI910583A0 (fi) | 1991-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0441605T3 (da) | Thiazolidin-derivater med anti-diabetisk virkning samt deres fremstilling og anvendelse | |
| DK0412404T3 (da) | Thiazolderivater, fremgangsmåder til fremstilling deraf og farmaceutiske præparater omfattende derivaterne | |
| JPS6479184A (en) | Pyrazolotriazine derivative | |
| EP0541120A3 (en) | Xanthine derivatives for the treatment of dementia | |
| ES8704445A1 (es) | Procedimiento de preparar derivados aminicos | |
| SE8406141D0 (sv) | N-acylaminosyradiamidderivat, salter derav, forfarande for deras framstellning och antiulcermedel innehallande dessa | |
| DE3665711D1 (de) | Novel guanidinomethylbenzoic acid derivatives | |
| DK0508740T3 (da) | Thiazolidindionderivater, deres fremstilling og anvendelse. | |
| ES2046229T3 (es) | Composicion antiulcerosa. | |
| ES510004A0 (es) | "un procedimiento para preparar derivados de n-naftoilglicina". | |
| FI881104A0 (fi) | Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi | |
| FI931346A0 (fi) | Butadienderivat och foerfarande foer deras framstaellning | |
| ATE168691T1 (de) | Makrolid-derivate | |
| ATE236162T1 (de) | Pyrroloazepinderivate | |
| DE3579189D1 (de) | Heterocyclische aminoverbindungen. | |
| DK14691A (da) | 4-substituerede anthracyclinoner og anthracyclinglycosider samt deres fremstilling | |
| IT1197841B (it) | Derivati pirido-benzotiazinici ad attivita' antibatterica ed a lunga durata di azione | |
| ATE112682T1 (de) | Isocarbacyclinderivate enthaltende antidiabetika. | |
| FI883507A0 (fi) | Naftotiazepinderivat och deras framstaellning. | |
| ATE129246T1 (de) | Pyrazolo(1,5-a)pyridine, deren herstellung und verwendung. |